Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.81% | 2.07% | -5.91% | 2.63% | 26.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.32% | 2.64% | -3.98% | 18.75% | 4.75% |
| Operating Income | -18.32% | -2.64% | 3.98% | -18.75% | -4.75% |
| Income Before Tax | -18.78% | -2.94% | 0.15% | -7.80% | 20.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.78% | -2.94% | 0.15% | -7.80% | 20.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.78% | -2.94% | 0.15% | -7.80% | 20.96% |
| EBIT | -18.32% | -2.64% | 3.98% | -18.75% | -4.75% |
| EBITDA | -17.96% | -2.17% | 4.56% | -19.53% | -4.84% |
| EPS Basic | 80.19% | 85.52% | 85.66% | 98.68% | -- |
| Normalized Basic EPS | 80.19% | 85.52% | 86.03% | 86.91% | -- |
| EPS Diluted | 80.19% | 85.52% | 85.66% | 98.68% | -- |
| Normalized Diluted EPS | 80.19% | 85.52% | 86.03% | 86.91% | -- |
| Average Basic Shares Outstanding | 499.57% | 610.97% | 596.51% | 723.43% | -- |
| Average Diluted Shares Outstanding | 499.57% | 610.97% | 596.51% | 723.43% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |